RecruitingPhase 1NCT06084299

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer

Studying Pediatric hepatocellular carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zhiyong Huang
Principal Investigator
Zhiyong Huang
Tongji Hospital
Intervention
Autologous Tumor Infiltrating Lymphocytes(biological)
Enrollment
16 enrolled
Eligibility
18-70 years · All sexes
Timeline
20202026

Study locations (1)

Collaborators

Wuhan Elongevity Technology Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06084299 on ClinicalTrials.gov

Other trials for Pediatric hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Pediatric hepatocellular carcinoma

← Back to all trials